Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Solid Biosciences (SLDB) Restructuring Costs (2020 - 2023)

Solid Biosciences' Restructuring Costs history spans 2 years, with the latest figure at $5.7 million for Q4 2022.

  • For Q4 2022, Restructuring Costs changed N/A year-over-year to $5.7 million; the TTM value through Dec 2023 reached $5.7 million, down 21.18%, while the annual FY2023 figure was -$63000.0, 100.88% down from the prior year.
  • Restructuring Costs for Q4 2022 was $5.7 million at Solid Biosciences, up from $1.5 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $5.7 million in Q4 2022 and bottomed at $1.5 million in Q2 2022.